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Summary
The signals that determine whether axons are en-
sheathed or myelinated by Schwann cells have long
been elusive. We now report that threshold levels of
neuregulin-1 (NRG1) type III on axons determine their
ensheathment fate. Ensheathed axons express low
levels whereas myelinated fibers express high levels
of NRG1 type III. Sensory neurons from NRG1 type III
deficient mice are poorly ensheathed and fail to my-
elinate; lentiviral-mediated expression of NRG1 type
III rescues these defects. Expression also converts
the normally unmyelinated axons of sympathetic neu-
rons to myelination. Nerve fibers of mice haploinsuffi-
cient for NRG1 type III are disproportionately unmy-
elinated, aberrantly ensheathed, and hypomyelinated,
with reduced conduction velocities. Type III is the
sole NRG1 isoform retained at the axon surface and
activates PI 3-kinase, which is required for Schwann*Correspondence: salzer@saturn.med.nyu.edu
10 Present address: Department of Neurobiology and Behavior,
State University of New York at Stony Brook, Stony Brook, New
York 11794.cell myelination. These results indicate that levels of
NRG1 type III, independent of axon diameter, provide
a key instructive signal that determines the ensheath-
ment fate of axons.
Introduction
Axons profoundly regulate Schwann cells during devel-
opment of the peripheral nervous system (PNS) (Jessen
and Mirsky, 2003). Mitogenic and trophic axonal signals
drive the generation of Schwann cells. Subsequently,
Schwann cells adopt one of two alternative phenotypes
distinguishable by their anatomic relationship to the
axon (Peters et al., 1991) and the repertoire of proteins
they express. Individual Schwann cells either ensheath
multiple small, unmyelinated axons—forming a Remak
bundle—or sort larger axons into a 1:1 relationship,
upregulate specific transcription factors and structural
proteins, and form a multilammelar myelin sheath around
the axon. This binary choice of axon ensheathment fates
is reflected in correspondingly distinct patterns of im-
pulse propagation, i.e., cable or saltatory conduction,
respectively.
Classic studies first performed more than a century
ago (Langley and Anderson, 1903), in which myelinated
and nonmyelinated nerves were cross-anastomosed,
demonstrated that axons determine the mode of Schwann
cell ensheathment and their subsequent phenotype
(Aguayo et al., 1976; Hillarp and Olivecrona, 1946; Simp-
son and Young, 1945; Weinberg and Spencer, 1976). My-
elination typically commences around axons with a di-
ameter of 1 m or greater, and above that size, myelin
sheath thickness is correlated to axon diameter (Peters
et al., 1991). These findings led to the hypothesis that a
critical axonal diameter triggers Schwann cell myelina-
tion, reflecting either the size of the axon (Friede, 1972;
Murray, 1968; Voyvodic, 1989) or the quantity of signal-
ing molecules on its surface (Spencer and Weinberg,
1978). An alternative hypothesis is that distinct cell sur-
face components are present on axons destined to be
myelinated that regulate Schwann cell differentiation.
Such molecules have yet to be identified.
Proteins encoded by the neuregulin-1 (NRG1) gene
(Adlkofer and Lai, 2000; Garratt et al., 2000a) are candi-
date axonal signals for regulating Schwann cell differenti-
ation. At least 15 different secreted or transmembrane
NRG1 isoforms resulting from alternative promoter usage
and RNA splicing are expressed by neurons and glia,
including Schwann cells (Falls, 2003a). These can be
classified into three major types (I, II, and III) that differ
in their amino terminal sequences (Garratt et al., 2000a;
Buonanno and Fischbach, 2001). Each isoform con-
tains an EGF domain that is sufficient to activate their
cognate receptors, members of the erbB family (Yarden
and Sliwkowski, 2001). NRG1 type III is the major iso-
form expressed by neurons that project into the PNS
(Ho et al., 1995; Meyer et al., 1997; Yang et al., 1998).
NRG1 has a key role at many stages of the Schwann
cell lineage (Garratt et al., 2000a). These include pro-
Neuron
682moting commitment of neural crest cells to the glial lin-
eage (Leimeroth et al., 2002; Shah et al., 1994) and the
proliferation, survival, and maturation of Schwann cells
and their precursors (reviewed in Garratt et al., 2000a).
Striking confirmation of NRG1’s importance in the
Schwann cell lineage is evidenced by the severe defi-
ciency of Schwann cells in mice with targeted disrup-
tions of the NRG1 gene or its receptors (Garratt et al.,
2000a). Isoform-specific NRG1 knockouts, and the pat-
tern of expression, provide compelling evidence that
type III is the key isoform required for Schwann cell
generation (Meyer et al., 1997; Wolpowitz et al., 2000).
The role of NRG1 in regulating axon ensheathment and
myelination by Schwann cells has remained elusive. Analy-
sis has been complicated by the failure of Schwann cells
to develop in mice with targeted mutations of NRG1 and
its receptors, together with the embryonic lethality of these
mice. Recent studies using transgenic and conditional
knockout strategies have established that levels of ax-
onal NRG1, signaling through the erbB2 coreceptor, de-
termine the number of lamellae that myelinating Schwann
cells form around axons (Garratt et al., 2000b; Michai-
lov et al., 2004). A fundamental unanswered question is
whether NRG1 also dictates the binary choice of axon
ensheathment fates by regulating the alternative phe-
notypes of Schwann cells. We now report that thresh-
old levels of NRG1 type III, independent of axon diame-
ter, provide the long-sought instructive signal that
determines whether axons become ensheathed or my-
elinated.
Results
NRG1 Type III Is Required for Ensheathment
and Myelination of Axons by Schwann Cells
We first examined the role of NRG1 type III in myelina-
tion by explanting dorsal root ganglia (DRG) from wild-
type (wt) and knockout (NRG1 type III−/−) mice (Wol-
powitz et al., 2000) into culture. Neurites from wt mice
were quickly repopulated by endogenous Schwann
cells migrating out from the explant and associating
with individual nerve fibers. In contrast, there was a
marked deficiency of Schwann cells in explants from
the NRG1 type III−/− mice (see Figure S1 in the Supple-
mental Data online); over time (weeks), such cultures
partially repopulated with endogenous Schwann cells.
Interestingly, many of the Schwann cells in the NRG1
type III−/− cultures preferentially grew out along the sub-
strate rather than attaching to the neurites, which in-
stead remained fasciculated and poorly ensheathed
(Figure S1). This phenotype was never observed in the
wt cocultures. These explant studies are consistent
with the known role of NRG1 type III in the generation
of Schwann cells and also suggest that NRG1 type III
is required for proper ensheathment.
To directly examine the role of NRG1 type III in en-
sheathment and myelination, mature Schwann cells,
isolated from postnatal rats, were plated onto estab-
lished cultures of either wt or NRG1 type III−/− DRG neu-
rons, thereby circumventing the requirement for NRG1
during the early Schwann cell lineage. Ascorbate was
added to the media to initiate myelination, and cocul-




























































wonditions, Schwann cells attached to both wt and
RG1 type III−/− neurites and persisted throughout the
eriod of coculture. Schwann cells were more closely
ligned with and draped around wt compared to NRG1
ype III−/− neurites based on S100 staining (data not
hown). Of particular note, Schwann cells extensively
yelinated wt and NRG1 type III+/− neurons but consis-
ently failed to myelinate NRG1 type III−/− neurons (Fig-
re 1Ad). The lack of myelin protein expression was
onfirmed by Western blotting culture lysates (Figure
B). Similarly, Oct-6/SCIP/Tst-1, a key transcription fac-
or of promyelinating Schwann cells (Scherer et al.,
994), is readily detected in wt but not in NRG1 type
II−/− cocultures (Figures 1B and 1C). These results indi-
ate that NRG1 type III is required for Oct-6 activation
nd myelin induction.
Typically, after several weeks, there were more
chwann cells in wt compared to the NRG1 type III−/−
ocultures (compare Figures 1Ac and 1Af), consistent
ith the known mitogenic and trophic effects of NRGs.
o exclude a failure of myelination in NRG1 type III−/−
ocultures due to limiting numbers of Schwann cells,
e added a 5-fold excess of Schwann cells (106/cover-
lip) to some NRG1 type III−/− neuron cultures. Despite
considerable excess of Schwann cells, these co-
ultures also failed to myelinate (data not shown).
chwann cells also failed to myelinate NRG1 type III−/−
eurons that had been grown continuously with BDNF
nd NT3 to promote survival of larger neurons that are
ormally more heavily myelinated (data not shown).
aken together these data demonstrate that NRG1 type
II is an essential neuronal signal for Schwann cell my-
lination of all size classes of DRG neurons, indepen-
ent of its mitogenic and trophic activity.
Abnormalities of ensheathment and myelination of
RG1 type III−/− axons were confirmed by electron mi-
roscopy (Figure 2). Several striking differences be-
ween these sets of cocultures were observed. The wt
ocultures were robustly myelinated, whereas no my-
lin was present in the NRG1 type III−/− cocultures. In
ddition, unmyelinated axons in the wt cocultures were
ully ensheathed and separated by Schwann cell pro-
esses, whereas many of the NRG1 type III−/− axons
acked any investment by Schwann cell processes, re-
aining directly in contact with other neurites. Other
RG1 type III−/− axons were only partially ensheathed
r were incompletely sorted into separate “pockets” of
he Schwann cell (Figures 2B and 2D, asterisks). Even
arge axons (>1 m) remained unsorted despite close
ssociation with Schwann cells (Figure 2F, asterisks).
hese studies confirm that Schwann cells do not my-
linate NRG1 type III−/− axons and indicate that NRG1
ype III is also required for proper segregation and en-
heathment of axons by Schwann cells.
RG1 Type III Expression Levels Determine
he Ensheathment Fate of Axons
e next asked whether NRG1 type III is not only neces-
ary but may provide the long-sought instructive signal
or Schwann cell myelination. We first confirmed that
RG1 levels were deficient in NRG1 type III−/− neurons
Figure 3A). Lysates from these neurons were probed
ith an antibody against an NRG1 epitope common to
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683Figure 1. NRG1 Type III Is Essential for
Schwann Cell Ensheathment and Myelination
(A) Rat Schwann cells were maintained in vi-
tro for 3 weeks with sensory neurons ob-
tained from wt (Aa–Ac) or NRG1 type III−/−
(Ad–Af) mice, fixed, and stained for the my-
elin protein P0 (Aa and Ad), neurofilament
(Ab and Ae), and cell nuclei (Ac and Af). Nu-
merous myelin segments are evident in wt
cultures; none form in NRG1 type III−/− cul-
tures. Scale bar, 100 m.
(B) Cocultures of wt, NRG1 type III+/−, and
NRG1 type III−/− neurons and rat Schwann
cells were maintained in myelinating condi-
tions for 8, 14, or 21 days; extracts prepared
from these cocultures were probed for P0,
MBP, and Oct-6. All proteins are detected in
extracts of wt cocultures at both day 14 and
day 21, are present at reduced levels in ex-
tracts of NRG1 type III+/− cocultures, and are
absent in extracts from NRG1 type III−/− co-
cultures. Oct-6 is detectable at day 14 in wt
and NRG1 type III+/− with longer exposures
(data not shown).
(C) Schwann cells were maintained with wt
and NRG1 type III−/− neurons for 15 days in
myelinating conditions and stained for Oct-6
(fluorescein), MBP (rhodamine), and with the
Hoechst nuclear dye (blue). Oct-6 is ex-
pressed in Schwann cell nuclei in the wt co-
cultures just prior to the onset of myelination;
no expression was observed in Schwann cells
cocultured with NRG1 type III−/− neurons.
Scale bar, 50 m.the “a” type cytoplasmic tail, the most abundant variant
expressed in the nervous system (Falls, 2003b). This
antibody recognizes the uncleaved type III (135 kDa)
and Ig (types I/II) NRG1 (105 kDa) pro-proteins as well
as an w65 kDa cleaved fragment of these isoforms
(Frenzel and Falls, 2001). The NRG1 type III pro-protein
(indicated with an arrow) was present in wt extracts,
significantly reduced in the NRG1 type III+/−, and unde-
tectable in the NRG1 type III−/− extracts (Figure 3A). Al-
though the 105 kDa type I NRG1 pro-protein is not visi-
ble in any of the extracts, an w65 kDa NRG1 band,
which likely corresponds to a cleaved NRG1 intracellu-
lar fragment, was prominently expressed in all of the
extracts, including the NRG1 type III−/− lane. Preincuba-
tion of the pan-neuregulin antibody with the peptide to
the cytoplasmic tail abolished staining of the 135 and
65 kDa bands, underscoring the specificity of the re-
sults (data not shown). These results indicate that
NRG1 type III+/− and NRG1 type III−/− neurons have re-
duced and deficient type III expression, respectively.
We next infected NRG1 type III−/− neurons with a len-
tivirus to drive expression of HA-tagged NRG1 type III.
This resulted in efficient and persistent expression of
NRG1 type III. Expression was comparable to that of
wt neurons based on Western blotting (Figure 3B). Live
staining for the HA tag indicated that NRG1 type III was
robustly expressed at the surface of many axons (Fig-
ure 3C). Addition of Schwann cells to these infected
NRG1 type III−/− neurons demonstrated a striking res-
cue of myelination to levels similar to wt neuron cocul-
tures based on immunofluorescence (Figure 3D) and
Western blotting for the myelin protein, P0 (Figure 3B).We also observed numerous examples of unusually
thick myelin sheaths after just 2 weeks of coculture in
myelinating conditions (Figure 3E); the most heavily
myelinated segments were on average twice as thick in
infected NRG1 type III−/− as compared to wt cultures
(Figure 3F). While the HA epitope was consistently
masked in cocultures, the sequential arrangement of
these segments along individual axons (Figure 3E) sug-
gests that those fibers may express unusually large
amounts of NRG1. These results indicate that deficient
myelination of NRG1 type III−/− neurons is specifically
due to the lack of NRG1 type III expression and demon-
strate that driving type III expression can result in a
substantial increase in the thickness of the myelin
sheath.
To address further a potential instructive role of
NRG1 type III in myelination, we compared the levels
of NRG1 on three sets of peripheral neurons: NGF-
dependent sympathetic neurons of the superior cervi-
cal ganglia (SCG), which are ensheathed but unmyelin-
ated; NGF-dependent neurons from DRGs, which are
thinly myelinated; and the larger BDNF- and NT3-
dependent neurons from DRGs, which are more consis-
tently and heavily myelinated (Snider and Wright, 1996).
Western blotting demonstrates that each set of neu-
rons express both NRG1 bands (Figure 4A). However,
SCG neurons express minimal levels of NRG1 type III,
whereas DRG neurons, particularly the BDNF- and NT3-
dependent neurons, express much higher levels. These
results provide an explanation for the relatively limited
mitogenic effects of SCG compared to DRG neurons
for Schwann cells (R. Devon and P. Wood, cited in
Neuron
684Figure 2. Ultrastructure of Schwann Cell Association with Wt and
NRG1 Type III−/− Neurites
Electron micrographs of cocultures of Schwann cells and wt (A, C,
and E) and NRG1 type III−/− (B, D, and F) neurons maintained for 60
days. Myelinated axons (MA) are common in wt cocultures. Inter-
ruptions in the surrounding myelin sheaths represent typical non-
compacted specializations of the myelin sheath; a thinly my-
elinated axon is also indicated (star) in panel (E). Smaller axons are
not myelinated, but are consistently ensheathed (arrowheads, [C
and E]). Despite apposition of Schwann cell processes, most axons
in NRG1 type III−/− cocultures lack any ensheathment or are incom-
pletely ensheathed (asterisks). No myelin is detectable in any of
the NRG1 type III−/− cocultures, and many large diameter axons
(asterisks, [F]) remain unsorted; one fully ensheathed fiber is appar-
ent ([F], arrowhead). Scale bars, 1 m (E and F), 2 m (A, B, D, and
















































hObremski et al., 1993). Importantly, they indicate that
levels of NRG1 vary widely on different axon types in a
manner correlated to their ensheathment fate. As each
lane was loaded with equal amounts of protein, NRG1
expression levels do not strictly correlate with axon size.
A key question is whether increasing the expression
of NRG1 type III in SCG neurons can promote myelina-
tion of these normally unmyelinated nerve fibers. To ad-
dress this possibility, SCG neurons cultured from P2
rats were infected with the NRG1 type III-lentiviral con-
struct. This resulted in detectable NRG1 type III expres-
sion, although the level of expression achieved after













in NRG1 type III−/− DRG neurons, based on staining for
he HA epitope (data not shown) and blotting for NRG1
Figure 4B). Rat Schwann cells were then added to con-
rol or infected SCG neurons, and cocultures were
aintained under myelinating conditions, fixed, and
tained for MBP expression. As expected, myelin seg-
ents were rarely observed in the cocultures of unin-
ected SCG neurons. In contrast, significant numbers
f myelin segments formed when Schwann cells were
ocultured with infected neurons (Figure 4C) and con-
inued to accumulate over time (data not shown). These
esults are quantitated in Figure 4D. This increase was
uite remarkable, considering the limited expression of
RG1 type III by these neurons. These results demon-
trate that expression of NRG1 type III by itself is suffi-
ient to switch axons that are normally unmyelinated to
myelinating fate and provide compelling evidence for
ts instructive role.
RG1 Type III Is the Sole NRG1 Isoform on the Axon
urface and Determines PI 3-Kinase Activity
esults of Western blotting suggested that sensory
eurons express several NRG isoforms: type III which
s expressed as an uncleaved pro-protein at the axon
urface and other, cleaved forms (Figure 3A). To deter-
ine if these other isoforms are expressed at the axon
urface, we incubated neurons with erbB2/3-Fc (Figure
); this chimeric protein contains the extracellular do-
ains of erbB2 and erbB3 fused to the Fc portion of
uman IgG and binds to NRG1 with high affinity (Fitz-
atrick et al., 1998). ErbB2/3-Fc bound strongly to wt
Figure 5Aa), modestly to NRG1 type III+/− (Figure 5Ab),
nd not at all to the NRG1 type III−/− neurons (Figure
Ac). The failure of erbB2/3-Fc to bind to NRG1 type
II−/− neurons indicates that type III is the sole NRG1
soform on the axon surface. Binding studies with
rbB2/3-Fc also corroborated that SCG neurites ex-
ress negligible amounts of NRG1 on their surface, that
hese levels increase after lentiviral infection, and are
igher still on DRG neurites (data not shown).
As type III is the only isoform expressed on the axon
urface, the inability of NRG1 type III−/− neurons to my-
linate suggests that contact-dependent signaling by
xons to Schwann cells might be impaired. To investi-
ate this possibility, we determined whether different
evels of NRG1 type III affected activation of two key
ignaling pathways in Schwann cells: PI 3-kinase,
hich is required for myelination; and MAP kinase ac-
ivity, which is not required and has been reported to
ave an opposing effect (Maurel and Salzer, 2000;
gata et al., 2004). We plated membranes prepared
rom wt, NRG1 type III+/−, and NRG1 type III−/− neuron
ultures onto Schwann cells for 20 min and then mea-
ured the levels of phospho-Akt, a key effector of PI
-kinase, and phospho-Erk (Figure 5B). Both signaling
athways were robustly activated when wt neurite
embranes were plated onto Schwann cells. Activation
f PI 3-kinase was consistently reduced with the NRG1
ype III+/− membranes and absent with the NRG1 type
II−/− membranes. In contrast, MAP kinase activation by
RG1 type III−/− neurite membranes was equivalent to
t membranes or only slightly reduced. These results
ndicate that NRG1 type III on the axon membrane is
NRG1 Type III Determines Axon Ensheathment Fate
685Figure 3. Forced Expression of NRG1 Type III
Rescues the Myelination Defect of NRG1
Type III−/− Neurons and Results in Hypermy-
elination
(A) Detergent lysates of wt, NRG1 type III+/−,
and NRG1 type III−/− DRG neurons were frac-
tionated by SDS PAGE and blotted with an
antibody to the “a-tail” C-terminal epitope.
The 135 kDa band corresponding to the full-
length NRG1 type III pro-protein (indicated
with an arrow) is present in wt, reduced in
NRG1 type III+/−, and completely missing in
NRG1 type III−/− lysates; a cleaved NRG1
band of w65 kDa is present in all extracts.
(B) Detergent lysates of cocultures of wt or
NRG1 type III−/− neurons infected (Vs#1) or
not with a lentiviral construct driving expres-
sion of an HA-tagged NRG1 type III con-
struct were probed with antibodies to NRG1
and P0.
(C) NRG1 type III expression by infected
NRG1 type III−/− neurons was detected by
live staining for the HA epitope (rhodamine);
neurons were double stained for the inter-
mediate filament protein peripherin (fluores-
cein). Scale bar, 40 m.
(D) Rescue of myelination of NRG1 type III−/−
neurons by expression of NRG1 type III is shown in cocultures double stained for MBP (rhodamine) and neurofilament (fluorescein). Scale
bar, 40 m.
(E) A fiber with hypermyelinated segments (indicated with white arrows) is illustrated. Scale bar, 40 m.
(F) Quantitation of hypermyelination showing the mean ± SEM. The thickest myelin segments in the infected NRG1 type III−/− cocultures were
approximately twice the thickness of those in uninfected wt cocultures (p < 0.0001).measured NRG activity in conditioned media from wt,
Figure 4. NRG1 Type III Expression Induces
Myelination
(A) Detergent lysates of SCG, NGF-depen-
dent, and BDNF/NT3-dependent DRG neu-
rons were fractionated by SDS PAGE and
blotted with an antibody to the “a-tail” C-ter-
minal epitope. The 135 kDa andw65 kDa are
present in all extracts although levels vary
considerably between these populations of
neurons
(B) SCG neurons were infected with two sep-
arate lentiviral stocks to drive expression of
NRG1type III. Detergent extracts were pre-
pared and blotted for NRG1 as shown; the
blot is slightly overexposed by comparison
to panel (A) to better show the increase in
NRG1 levels.
(C) Cocultures of Schwann cells and control
(left) or SCG neurons infected with NRG1
type III lentivirus were stained for MBP (rho-
damine) and neurofilament (fluorescein). Scale
bar, 100 m.
(D) Quantitation of the number of myelin seg-
ments in control and infected SCG cocultures from two separate experiments (four coverslips/condition/experiment) showing the mean ± SEM.
The increase in the number of myelin segments is statistically significant (**p = 0.006, ***p = 0.0005).
into rat DRG neurons. Neurons were grown for an addi-the key activator of PI 3-kinase and that activation is
graded to the levels of NRG1type III. They also strongly
suggest that other non-NRG1 signals on the axon acti-
vate MAP kinase.
Ig-NRG1 Isoforms Are Shed
by Metalloproteinase Cleavage
To determine whether other NRG isoforms expressed
by NRG1 type III−/− neurons are cleaved and shed, weNRG1 type III+/−, and NRG1 type III−/− neuron cultures
using a sensitive bioassay (Esper and Loeb, 2004). Sig-
nificant and comparable amounts of NRG1 were re-
leased from wt, NRG1 type III+/−, and NRG1 type III−/−
neurons (Figure 5C). In each case, the NRG activity was
largely blocked by incubation with soluble heparin, in-
dicating that it reflects Ig (type I or II) isoforms. To ex-
amine the mechanism of shedding, cDNA constructs
encoding HA-tagged NRG1 isoforms were nucleofected
Neuron
686Figure 5. Type III Is the Sole Isoform on the Axon Surface and Regulates PI 3-Kinase Activity
(A) Cultures of wt, NRG1 type III+/−, and NRG1 type III−/− neurons were incubated with erbB2/3-Fc and then fixed and visualized with rhoda-
mine-conjugated anti-human Fc antibodies (Aa–Ac); neurofilament staining from the corresponding fields is shown (Ad–Af). ErbB2/3-Fc binds
strongly to wt (Aa), modestly to NRG1 type III+/− (Ab), and not at all to NRG1 type III−/− neurons (Ac). Scale bar, 40 m.
(B) Membranes prepared from wt, NRG1 type III+/−, and NRG1 type III−/− neurons were centrifuged onto Schwann cell cultures, and after 20
min, lysates were prepared, blotted, and probed for phospho-Akt, total Akt, and phospho-erk as shown.
(C) NRG levels were assayed in culture media from wt, NRG1 type III+/−, and NRG1 type III−/− neurons by measuring erbB receptor phosphory-
lation in L6 myotubes. A representative Western blot revealing erbB receptor phosphorylation is shown. Following the phosphotyrosine (pY)
Western blot, the membrane was stripped and reprobed for total erbB. The ratio of pY to total erbB is a quantitative measure of the amount
of NRG in the media. Results from two separate experiments are shown below (mean ± SD).
(D) Rat DRG neurons were nucleofected with HA-tagged NRG1 type III (Da–Dc) or type I (Dd–Di) constructs were stained for HA (Da, Dd, and
Dg) and peripherin (Db, De, and Dh); merged images (Dc, Df, and Di) are also shown. NRG1 type III is expressed at the axon surface (Da),
whereas type I NRG1 is detectable at the surface of neurons treated for 48 hr with the MMP inhibitor GM 6001 (Dg) but not in untreated
cultures (Dd). Scale bar, 40 m.tional 3 weeks, live stained for HA, fixed, permeabilized,
and stained for peripherin to visualize nerve fibers. In
agreement with its expression in NRG1 type III−/− neu-
rons (Figure 3C), the epitope tag of NRG1 type III was
present on the extracellular surface of rat sensory neu-
rons (Figure 5Da). In contrast, type I NRG1 was not ex-
pressed at the surface of these axons (Figure 5Dd) un-
less neurons were also treated for 48 hr with the








tr GM 6001 (Figure 5Dg). Thus, MPs differentially regu-
ate the expression of NRG1 isoforms at the surface of
eurons; type III is retained, whereas Ig forms are shed.
RG1 Type III Is an Instructive Juxtacrine Signal
hat Requires Other Axonal Signals
s NRG1 type III−/− neurons are poorly ensheathed and
nmyelinated, the released Ig isoforms are not func-
ionally redundant with the type III isoform, suggesting
NRG1 Type III Determines Axon Ensheathment Fate
687that type III may promote ensheathment and myelina-
tion only as a contact-dependent signal. We thus ex-
amined the efficacy of a paracrine source of NRG1 type
III in rescuing myelination in the NRG1 type III−/− cocul-
tures. We supplemented the media of the NRG1 type
III−/− cultures with a recombinant, soluble form of the
type III ectodomain (sECD), which retains its mitogenic
effect and ability to activate downstream signaling
pathways in rat Schwann cells (Figure S2). Cocultures
were maintained in myelin-promoting media, supple-
mented with sECD at 1 or 10 nM for up to 30 days.
Despite addition of sECD, NRG1 type III−/− cocultures
failed to myelinate (Figure 6A). Interestingly, the sECD
was effective in promoting repopulation of NRG1 type
III−/− neurites when only small numbers of Schwann
cells were added to these neurons (data not shown).
Together, these findings indicate that type III is effective
in promoting proliferation as a paracrine or a juxtacrine
signal, but is effective in promoting myelination only as
a juxtacrine signal.
We also investigated whether a heterologous, jux-
tacrine source of NRG1 type III can induce myelin pro-
tein expression in Schwann cells. We transfected CHO
cells with NRG1 cDNA constructs and selected for cells
expressing high levels of the HA-tagged NRG1 type III
(CHO-III). Rat Schwann cells were then plated onto
confluent monolayers of either CHO-III or control (non-
transfected) CHO cells (Figure 6B). Cultures were main-
tained for 14 days in myelinating conditions and fixed.
Schwann cells were stained with S100 antibodies and
MBP expression was assessed. There was a significant
accumulation of Schwann cells grown on the CHO-III
monolayers over time compared to control CHO cells,
confirming that NRG1 type III expressed on CHO cells
retains its activity as a mitogen. However, no MBP ex-Figure 6. NRG1 Type III Induces Myelination as a Juxtacrine Signal from Axons
(A) Schwann cells were grown with wt and NRG1 type III−/− neurons in myelinating conditions for 14 days without (control) or with the addition
of 1 nM or 10 nM of recombinant, soluble extracellular domain of type III (sECD). Cultures were fixed and stained for MBP (rhodamine) and
cell nuclei (Hoechst, blue). Numerous myelin segments are present in wt cocultures but none in NRG1 type III−/− cocultures, even when
supplemented with sECD.
(B) Schwann cells were plated onto control CHO cells (Ba and Bb) or CHO cells that stably express NRG1 type III (Bc and Bd). After 14 days,
Schwann cells were stained for S100 (fluorescein, [Ba and Bc]) and MBP (rhodamine, [Bb and Bd]). There was a marked increase in the
number of Schwann cells grown on the CHO-III cell monolayer but no MBP expression was detected. Scale bars, 100 m.pression was observed even after 1 month of coculture.
These results indicate that NRG1type III, while neces-
sary and instructive, requires other signals present on
the axon to induce Schwann cell myelination.
NRG1 Type III +/− Mice Are Hypomyelinated
and Exhibit Ensheathment Defects
To extend these findings, we characterized PNS my-
elination and ensheathment in NRG1 type III+/− mice,
which are viable and appear phenotypically normal in
contrast to NRG1 type III−/− mice which die at birth
(Wolpowitz et al., 2000). We first confirmed that NRG1
levels were reduced at all developmental stages in the
PNS of NRG1 type III+/− compared to wt mice, in agree-
ment with in vitro results (Figure 7A). We next compared
the expression of myelin transcription factors (Figure
7A) and the myelin proteins P0 and MBP (Figure 7B)
in wt and NRG1 type III+/− sciatic nerve. Each showed
significant reductions in the heterozygotes. Thus, my-
elin protein levels normalized to actin were decreased
by w30%–50%; similar results were observed for MAG
(data not shown). Reductions were apparent at all ages,
indicating that it reflects true hypomyelination and not
a delay in the onset or progression of myelination.
Changes were myelin specific, as neurofilament and
actin expression were comparable to or slightly in-
creased in the NRG1 type III+/− sciatic nerve lysates
(Figure S3). These results corroborate a key role of
NRG1 type III in myelination.
Reduction in myelin protein levels could result from
a lower percentage of myelinated axons, thinner myelin
sheaths, or both. Quantitation of axon ensheathment
on electron micrographs demonstrated that the propor-
tion of myelinated axons is reduced in the PNS of NRG1
type III+/− mice (Table 1); thus, 41% of fibers are my-
Neuron
688Figure 7. NRG1 Type III+/− Mice Are Hypomyelinated and Aberrantly Ensheathed
(A) Extracts were prepared from sciatic nerve at the postnatal time points shown and fractionated by SDS-PAGE, blotted, and probed with
antibodies NRG1 and the transcription factors Oct-6 and Krox-20.
(B) Semiquantitative analysis of PNS myelin protein levels was performed by probing Western blots with 125I protein A and quantitating by
PhosphorImager analysis. Myelin protein levels are normalized to actin as indicated; the means (±SEM) from two different experiments
are shown.
(C) Electron micrographs of Remak bundles in sciatic nerves from wt (left panels) and NRG1 type III+/− (right panels) adult mice show altered
axonal segregation; insets are shown at higher magnification in the lower panels. In the wt mice, axons (A) are fully ensheathed by Schwann
cell processes (Sc), whereas NRG1 type III+/− axons frequently directly appose each other without intervening Schwann cells processes. All
of the profiles seen in the inset from the NRG1 type III+/− mice are axons, a number of which are flattened or elongated in cross-section.
Scale bar, 1 m.
(D) The number of axons per Ramak bundle for wt and NRG1 type III+/− sciatic nerves were binned into separate groups and are shown as a
percentage of the total axons. Over 120 bundles for each genotype were counted (n = 2 mice of each genotype). The maximum number of
axons/bundle in the wt mice was 34; in NRG1 type III+/− mice, bundles containing up to 60 unmyelinated fibers were observed (p < 0.0001).
(E) The percentages of axons in Schwann cell pockets in Remak bundles were binned into four categories: a single axon/pocket; 2–10 axons/
pocket; 11–20 axons/pocket, and 21–35 axons/pocket. Over 800 unmyelinated axons for each genotype (n = 2) were counted. While almost
all axons are present in individual Schwann cell pockets in wt nerves, the number in NRG1 type III+/− nerves is significantly reduced (**p =
0.006). The maximum number of axons per pocket in the wt nerves was 7 versus 35 in the NRG1 type III+/− nerves (***p < 0.0001).elinated in wt mice, whereas only 28% were myelinated
in NRG1 type III+/− littermates. These results strongly
suggest that fibers that would normally be myelinated
in wt mice are unmyelinated in NRG1 type III+/− mice
and are consistent with culture studies indicating that
the level of NRG1 type III controls the binary choice
between ensheathment and myelination. In agreement
with a recent report (Michailov et al., 2004), myelin
sheaths in NRG1 type III+/− sciatic nerves are thinner
than comparably sized fibers in wt mice (Figure S4).
Morphometry confirmed a significant increase in the g











fII+/− versus wt mice (Table 1 and Figure S4) but compa-
able axon diameters in adults (wt 3.31 m ± 0.12 ver-
us NRG1 type III+/− 3.30 m ± 0.13; mean ± SEM). The
ltrastructural appearance and periodicity of myelin la-
ellae were also unaltered (Figure S4), indicating that
ifferences in myelin sheath thickness are due to differ-
nces in the number of lamellae.
The organization of the Remak bundles was also
uite different in the heterozygotes (Figure 7 and Table
). In NRG1 type III+/− mice, nonmyelinating Schwann
ells associate with more axons, and these axons are
requently incompletely segregated into Schwann cell
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689Table 1. Morphometric and Physiological Analyses of Wt and NRG1 type III+/− Nerves
+/+ +/−
% myelinated 40.5% 27.8%
% unmyelinated 59.5% 72.2% p < 0.0001
g ratios 0.68 ± 0.004 0.73 ± 0.004 p < 0.0001
Unsegregated axons/Remak bundle 5% 25% p < 0.0001
# axons/Remak bundle 8.7 13.1 p < 0.0001
NCV Myelinated (37°C) 39.89 ± 3.75 31.93 ± 2.29 p = 0.01
NCV C fibers (37°C) 0.61 ± 0.04 0.46 ± 0.02 p = 0.006
Summary of the morphometric analyses performed in adult wt and NRG1 type III+/− mice showing the g ratio values for sciatic nerve, the
percentage of unmyelinated and myelinated fibers in sciatic nerves, and the percentage of unsegregated axons in Remak bundles.
Morphologic analyses were performed using NIH Image J and Prism software. G ratios were calculated from the data set in Figure S4.pockets (Figure 7C). Remak bundles in NRG1 type III+/−
nerves had w50% more axons per Schwann cell than
in the wt nerves. There were several examples of more
than 50 axons/bundle in NRG1 type III+/− nerves; wt
nerves rarely had more than 30 axons/Remak bundle
(Figure 7D), consistent with a recent report (Murinson
and Griffin, 2004). In addition, many of the axons in Re-
mak bundles of NRG1 type III+/− mice were not appro-
priately segregated into separate pockets of the
Schwann cell but rather were bundled together as axon
fascicles and lacked intervening Schwann cell pro-
cesses. Wild-type nerves rarely contained more than
seven axons/pocket, whereas NRG1 type III+/− nerves
had as many as 35 axons/pocket (Figure 7E). Interest-
ingly, many of the bundled axons in the NRG1 type III+/−
nerves were tightly packed together and exhibited flat-
tened, elongated profiles. These findings suggest that
Schwann cell ensheathment is required for appropriate
axon morphology in the adult. Corresponding abnor-
malities of nerve conduction velocity (NCV) were ob-
served, with both Remak/C fibers and myelinated fibers
in the heterozygotes conducting significantly more
slowly than their wild-type counterparts (Table 1 and
Figure S5). In addition, C fiber traces were typically
more heterogeneous and exhibited reduced amplitudes
in NRG1 type III+/− mice compared to their wt litter-
mates (Figure S5).
Taken together, these findings indicate that limiting
amounts of NRG1 type III increased the proportion of
unmyelinated axons, resulted in aberrant sorting and
ensheathment of axons in Remak bundles, thinner
sheaths, and corresponding abnormalities of nerve
conduction. A summary of morphologic abnormalities
observed in the heterozygotes and cultures are il-
lustrated in Figure 8.
Discussion
The nature of the signal(s) that determines whether ax-
ons are ensheathed or myelinated has long been elu-
sive. We demonstrate here that NRG1 type III regulates
the binary choice between ensheathment and myelina-
tion in the PNS. Low levels are required for ensheath-
ment of PNS axons, while high levels trigger myelina-
tion. At levels above this threshold, the amount of
myelin formed is graded to the levels of NRG1 type III.mine the number of axons per Remak bundle.
Figure 8. Schematic Summary of Abnormalities in Nerves with
Altered NRG1 Type III Levels
Alterations in axon ensheathment and myelination as a function of
NRG1 type III levels are illustrated based on in vivo and in vitro
analysis. In wt mice, unmyelinated axons in the PNS are segregated
into separate pockets of Remak bundles and myelinated axons are
fully wrapped. In NRG1 type III+/− mice, a greater proportion of ax-
ons remain unmyelinated and are frequently fasciculated together
in Remak bundles, sometimes with distorted cross-sectional pro-
files; myelinated axons have thinner sheaths. In the absence of
NRG1type III, Schwann cells fail to ensheath axons and even large
axons remain unsegregated and unmyelinated.NRG1 Type III Is an Essential Signal for Ensheathment
and Myelination in the PNS
Peripheral nerves contain a mixture of small, unmyelin-
ated axons organized as Remak bundles and larger,
myelinated axons. The axonal signals that determine
whether axons are ensheathed or myelinated have
been thought to be distinct. Findings in this study indi-
cate that NRG1 type III plays an essential role in both
processes. Its crucial role in ensheathment is most
strikingly demonstrated by the failure of Schwann cells
in cocultures to wrap NRG1 type III−/− neurites or to
physically sort even larger axons into a 1:1 relationship,
despite attachment to these fibers (Figure 2). Remak
bundles in the NRG1 type III+/− mice exhibit intermedi-
ate defects of ensheathment characterized by persis-
tence of unsegregated axon fascicles together with a
marked increase in the number of unmyelinated axons
per Schwann cell (Figure 7). These results indicate that
sorting and ensheathment of axons by Schwann cells
require NRG1 type III signaling and that its levels deter-
Neuron
690Our studies also indicate that full ensheathment of
axons is necessary for normal morphology of unmyelin-
ated axons and conduction velocity in C fibers (Figure
7 and Figure S5). Abnormalities of C fiber conduction
in the heterozygotes likely reflect an altered microenvi-
ronment, as many of these axons were incompletely
ensheathed by Schwann cell processes and, conse-
quently, not electrically isolated. These findings differ
from those of a recent study (Chen et al., 2003) in which
overexpression of a dominant-negative (truncated) erbB4
in adult, nonmyelinating Schwann cells resulted in in-
creased numbers of Schwann cells and fewer axons
per Remak bundle. These differences probably reflect
distinctions in the animal models used. The studies of
Chen et al. focused on the role of erbB signaling in
adult Remak bundles, and hence their maintenance,
rather than their formation. In addition, overexpression
of this mutant erbB4 receptor may have gain-of-func-
tion effects or, alternatively, block erbB signaling pro-
vided by other EGF-related ligands in peripheral nerves
(Ling et al., 2005).
A striking finding of the current study was the consis-
tent failure of Schwann cells to myelinate NRG1 type
III−/− axons (Figures 1 and 2). This failure may result, in
part, from the inability of Schwann cells to segregate
NRG1 type III−/− axons into a 1:1 relationship, a likely
prerequisite for myelination (Peters et al., 1991). How-
ever, NRG1 type III also directly regulates myelination
itself apart from its role in axon segregation. Myelina-
tion is strictly dependent on the activation of a series
of transcription factors, including Oct-6 and Krox-20
(Jessen and Mirsky, 2003). Expression of both of these
transcription factors requires axonal signals (Murphy et
al., 1996; Scherer et al., 1994). We have shown that ex-
pression of these transcription factors is sensitive to
the levels of NRG1 on the axon (Figures 1 and 7). These
results are consistent with studies showing that mem-
brane-associated, but not soluble, NRG1 type III induces
Oct-6 expression in multipotential crest-derived progeni-
tors (Leimeroth et al., 2002). Reduced expression of tran-
scription factors in the PNS of heterozygotes, in turn,
likely accounts for the reduction of myelin proteins and
the thinner myelin sheaths of appropriately segregated
axons. Taken together, these findings indicate that
NRG1 type III is essential for Schwann cell myelination
by promoting the physical sorting of large axons and
regulating the expression of key transcription factors.
While our data demonstrate that NRG1 type III is nec-
essary for PNS myelination, they also show that it is not
sufficient (Figure 6B). Candidate molecules that may
act in concert with NRG1 type III include cell adhesion
molecules on the axon surface as well as signals from
the extracellular matrix (Bunge et al., 1986) and growth
factors such as the neurotrophins (Chan et al., 2004;
Cosgaya et al., 2002) and GDNF (Chen et al., 2003;
Hoke et al., 2003).
Threshold and Graded Effects of NRG1 Type III
on Myelination
This study establishes NRG1 type III as a key axonal
signal that determines the binary choice between en-
sheathment and myelination. Thus, Schwann cells fail




























































oII+/− sciatic nerves are substantially hypomyelinated
ue, in part, to a reduction in the proportion of my-
linated fibers (Table 1). The latter result suggests that
ibers that would normally be myelinated are instead
resent in Remak bundles. In potential agreement, a
umber of unmyelinated axons in the type III heterozy-
otes had very large axon circumferences; some were
early twice that of the smallest myelinated fibers in wt
erves (data not shown).
We have also shown that NRG1 levels on different
iber types correlate with their ensheathment fate. SCG
eurites, which are poorly ensheathed by Schwann
ells in cocultures (Obremski et al., 1993), express neg-
igible levels of NRG1 (Figure 4A). In contrast, DRG neu-
ites, which express much higher levels of NRG1, are
ully ensheathed and many fibers become myelinated.
he highest expression of NRG1 is by the heavily my-
linated, BDNF/NT3-dependent neurons (Figure 4A).
hese findings also indicate that expression of NRG1
s independent of axon diameter. Thus, SCG and NGF-
ependent DRG neurons have fibers of comparable di-
meter when cultured in the absence of Schwann cells
Estridge and Bunge, 1978; Windebank et al., 1985) yet
xpress widely different levels of NRG1 even with cor-
ection for protein loading (Figure 4). Differences in
RG1 levels on these neurons appear to result from
oth transcriptional (Marchionni et al., 1993) and post-
ranscriptional mechanisms; the latter is consistent
ith limited expression even after lentiviral infection.
Remarkably, expression of NRG1 type III not only res-
ues myelination of the NRG1 type III−/− neurites and
eads to hypermyelinated segments (Figure 3) but also
romotes myelination of SCG neurites (Figure 4). SCG
ibers are nearly uniformly unmyelinated and fail to in-
uce myelin protein expression by Schwann cells in vivo
nd in vitro (Brunden et al., 1992; Roufa et al., 1986).
owever, even with modest expression of NRG1 type
II in SCG neurons, there is a significant increase in my-
lination (Figures 4C and 4D). These results indicate
hat expression of this single molecule is sufficient to
lter the ensheathment fate of the axon.
Together, these results provide compelling evidence
hat a threshold level of NRG1 type III is critical in deter-
ining which axons become myelinated. Neurites that
re normally myelinated express NRG1 type III at sub-
tantial levels but are unmyelinated in its absence; neu-
ites that are normally unmyelinated express limited
mounts and become myelinated with its expression.
aploinsufficiency results in a shift from myelinated to
nmyelinated fibers in peripheral nerves. Above thresh-
ld levels, myelin sheath thickness is graded to the
mount of NRG1 type III (Figures 3E, 3F, and 7), in
greement with Michailov et al. (2004). It has long been
nown that axon diameter (Friede and Samorajski,
967) and surface area (Smith et al., 1982) are strongly
orrelated to the number of myelin lamellae generated
n the PNS. Our data indicate that large axons not only
ave increased surface area but also express greater
mounts of NRG1 per unit membrane area (Figure 4A).
mplications for the Mechanisms of Ensheathment
nd Myelination
RG1 isoforms are synthesized as secreted proteins
r as membrane-spanning precursors (pro-NRGs). We
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691have demonstrated that pro-NRGs undergo MP cleav-
age in neurons: heparin binding (Ig) forms are shed as
soluble NRGs, whereas only type III is retained at the
membrane (Figures 5A and 5D), presumably via its hy-
drophobic N terminus, in agreement with studies in het-
erologous cells (Cabedo et al., 2002; Schroering and
Carey, 1998; Wang et al., 2001). These findings indicate
that type III functions as a juxtacrine signal and type I
as a paracrine signal as previously proposed (Falls,
2003b). They also suggest that these distinct modes of
signaling have important functional consequences.
Indeed, NRG1 type III promotes ensheathment and my-
elination via a juxtacrine mechanism since the addition of
soluble NRG1 type III to the culture media does not res-
cue the myelination defect in the NRG1 type III−/− cocul-
tures (Figure 6). The reason why NRG1 type III is much
more effective as a juxtacrine signal in promoting my-
elination is not known, although several possibilities
may be considered. Potentially, membrane tethering
would enhance receptor activation by concentrating
the ligand at the axon surface and provide for sustained
activation. In contrast, a soluble ligand is likely to have
more transient effects; indeed, we have previously
found that a soluble NRG downregulates erbBs on
Schwann cells within a few hours, which would limit the
duration of its effects (Zanazzi et al., 2001). Short-term
and long-term signaling by growth factors, or signaling
components such as PI 3-kinase, are known to have
very distinct effects on differentiation (Auger et al.,
2000; Marshall, 1995). Another possibility is that NRG1
on the axon surface would activate only those recep-
tors localized on the adaxonal glial membrane, whereas
soluble NRG1 may activate receptors on the abaxonal
membrane. Determining the functional consequences
of modifying the duration of NRG1 type III signaling and
activating receptors with different subcellular localiza-
tions on the Schwann cell will be of considerable inter-
est for future study.
Although Schwann cells fail to ensheath NRG1 type
III−/− axons in the cocultures, they do attach to and
appose these neurites (Figures 2D and 2F). Axon-
Schwann cell apposition is mediated by cell adhesion
molecules expressed by Schwann cells and axons,
such as N-cadherin and L1 (Haney et al., 1999; Wanner
and Wood, 2002). This study indicates that, while these
adhesion molecules are necessary for attachment, they
are not sufficient for ensheathment; rather, they require
activation of intracellular signaling pathways by NRG1
type III. The PI 3-kinase pathway is likely to mediate
many of the downstream effects of NRG1 type III. We
show here that NRG1 type III is the key signal on the
axon that regulates the activity of PI 3-kinase in
Schwann cells and this activation is graded to NRG1
levels (Figure 5B). PI 3-kinase activity is known to be
required for appropriate axon segregation and is essen-
tial for and promotes subsequent Schwann cell my-
elination (Maurel and Salzer, 2000; Ogata et al., 2004).
Indeed, the defects of the NRG1 type III−/− cocultures
phenocopy the failure of axon sorting and myelin initia-
tion in cocultures in which PI 3-kinase activity is
blocked (Maurel and Salzer, 2000).
Together, these studies suggest a model for myelina-
tion in which cell adhesion molecules promote glial
apposition and NRG1 type III on the axon surface, viaactivation of PI 3-kinase signaling at the inner glial
membrane, promotes ensheathment and myelination.
Our data also suggest that different levels of activation
regulate these different outcomes. Both NRG and PI
3-kinase have been implicated in the reorganization of
the actin cytoskeleton required for cell motility and la-
mellipodia formation in other cell types (for example,
see Nagata-Ohashi et al., 2004). Future studies to eluci-
date how graded signaling of NRG1 regulates effectors
of PI-3 kinase and the glial cytoskeleton, as well as
identification of NRG1-independent axonal signals, in-
cluding those that activate MAP kinase (Figure 5B), will
provide important insights into the mechanisms by
which NRG1 type III dictates distinct axon ensheath-
ment fates.
NRG1 Type III Coordinates Schwann Cell Numbers
to Cell Fate
NRG1 has now been implicated as an axonal signal that
regulates a remarkable range of stages in the lineage
of Schwann cells. NRG1 promotes the generation of
Schwann cells via commitment of neural crest cells to
the glial lineage and the proliferation, survival, and mi-
gration of Schwann cells and their precursors (Garratt
et al., 2000a; Mahanthappa et al., 1996; Meintanis et
al., 2001; Morrissey et al., 1995), thereby regulating
Schwann cell numbers along the axon. As we have
shown here, NRG1 also regulates the Schwann cell
phenotype. An important question is why a single mole-
cule has such a prominent role in regulating Schwann
cells at so many different points of their lineage.
We suggest that the dual regulation of Schwann cell
generation and differentiation by NRG1 type III coordi-
nates Schwann cell numbers to their alternative pheno-
types. In Remak bundles, multiple axons are associ-
ated with a single Schwann cell, requiring relatively few
Schwann cells per axon; in contrast, Schwann cells
have a unitary relationship with an axon in myelinated
fibers requiring a higher density of Schwann cells per
axon. The lower levels of NRG1 type III characteristic
of neurons with unmyelinated axons would be ex-
pected to generate fewer Schwann cells and promote
an ensheathing, nonmyelinating phenotype. In con-
trast, axons that express higher levels of NRG1 type III
would generate the additional Schwann cells required
by myelinated fibers and, subsequently, drive axon seg-
regation and myelination as shown here.
Experimental Procedures
Mice and Genotyping
Generation of NRG1 type III knockout mice has been described
previously (Wolpowitz et al., 2000). Mice were genotyped by PCR
using the following primers: 5#-ACTTTCTTCTTCCCATTCTGT-3#,
5#-TTTACTCTTCCTTACGGTCTA-3#, and 5#-TTTCTCTTGATTCCC
ACTTTG-3#. PCR was carried out at 94°C for 30 s, 52°C for 60 s,
and 72°C for 60 s, followed by 10 min extension at 72°C for 30
cycles. The expected 700 nt product for wild-type allele and 734 nt
product for the mutant allele were separated on a 2% agarose gel.
Cell Cultures
Mouse and rat DRG were isolated from E14.5 and E16.5 embryos,
respectively, and established on collagen-coated glass coverslips
as described (Zanazzi et al., 2001). Explants were cycled with
FUDR to eliminate all nonneuronal cells. Neuronal media was sup-
Neuron
692plemented with 50 ng/ml NGF (Harlan, Bioproducts for Science)
and, in some cases, 25 ng/ml BDNF (PeproTech) and 10 ng/ml NT3
(Austral Biologicals). Primary rat Schwann cells were prepared as
described (Einheber et al., 1997) and maintained in DMEM (Bio-
Whittaker), 10% FBS (Hyclone Laboratories), 2 mM L-glutamine (In-
vitrogen), until used. Rat Schwann cells (200,000 cells/coverslip)
were added to established explant cultures of DRG neurons, and
myelination was initiated by supplementing media with 50 g/ml
ascorbic acid (Sigma-Aldrich). Phase contrast images of wt and
NRG1 type III−/− Schwann cell neuronal cocultures were acquired
using an Axiovert 100 microscope (Zeiss).
SCG neurons were isolated from P2 Sprague-Dawley rats, stripped
of their cellular capsule, dissociated in 0.1% trypsin (Sigma-Aldrich)
and 1 g/ml DNase (Sigma-Aldrich), and triturated. Approximately 0.8
ganglia were placed on collagen-coated coverslips, and cultures
were maintained in Neurobasal Media (Invitrogen) supplemented
with 0.4 g/L glucose (Sigma-Aldrich), B27 supplements (Invitrogen),
and 50 ng/ml NGF. Cultures were cycled with FUDR to eliminate
nonneuronal cells and were repopulated with primary rat Schwann
cells as for DRG cultures. Culture media was supplemented with
50 g/ml of ascorbic acid in myelination studies. To quantitate the
extent of myelination, the total number of myelin segments, stained
with MBP, was counted in each coverslip (total of eight coverslips
per condition).
Rat DRG neurons were transfected with pcDNA3.1 vector con-
taining either NRGβ1a type I or NRGβ1a type III tagged with an HA
epitope (Wang et al., 2001), immediately after dissection using the
Rat Neuron Nucleofector kit (Amaxa Biosystems). Neurons were
cycled with antimitotics and maintained for 21 days prior to analy-
sis. In some cases, nucleofected neurons were treated with metal-
loprotease inhibitors (10 M or 100 M GM 6001 or 20 M or 200
M TAPI-1; both from Calbiochem) for 48 hr prior to analysis. CHO
cells were transfected with NRGβ1a type III HA using Lipofect-
amine 2000 (Invitrogen). Transfectants were selected with G418
(Invitrogen), pooled, live stained for the HA epitope, and FACS
sorted for high-level expression using the MoFlo DakoCytomation
FACScan. Expression was confirmed by Western blotting and bind-
ing of erbB2/3-Fc.
Antibodies and Immunofluorescence
Mouse monoclonal antibodies included anti-MBP (SMI-94, SMI-
99), neurofilament (SMI-31 and SMI-32) (Sternberger Monoclonals),
and HA 1.1 (Covance). Rabbit polyclonal antibodies included anti-
NRG sc348 (Santa Cruz), MBP (DakoCytomation), MBP (Chemi-
con), MAG, P0 (M. Filbin, Hunter College, New York, NY), actin
(Sigma-Aldrich), Oct-6 (D. Meijer, Erasmus University, Rotterdam,
Netherlands), Krox-20 sc190 (Santa Cruz), peripherin (Chemicon In-
ternational), S100 (DakoCytomation), phospho-AKT, total AKT, and
phospho-MAP kinase (Cell Signaling Technologies). Secondary an-
tibodies conjugated to rhodamine, fluorescein, or HRP were ob-
tained from Jackson Immunoresearch. Cocultures were permeabi-
lized in methanol and stained as described previously (Zanazzi et
al., 2001) and examined by epifluorescence on a Nikon E800 micro-
scope and by confocal microscopy on a Zeiss LSM 510.
Preparation of Detergent Lysates and Immunoblotting
Tissues and cell cultures were Dounce homogenized in a lysis
buffer containing 2% SDS, 95 mM NaCl, 10 mM EDTA, 1 mM PMSF,
10 g/ml aprotinin, 20 M leupeptin, 1 mM orthovanadate, and 2.5
mM sodium pyrophosphate in 25 mM Tris buffer (pH 7.4). Protein
concentrations were determined by the BCA method (Pierce); sam-
ples (20–40 g of protein) were fractionated by SDS-PAGE and
blotted onto nitrocellulose (Protran Biosciences). Appropriate re-
gions were excised, incubated with specific primary and secondary
antibodies, and developed with the SuperSignal chemiluminescent
substrate (Pierce). To compare levels of MBP, P0, and MAG, nitro-
cellulose membranes were incubated with the appropriate primary
antibody followed by 125I-labeled protein A (Valeant ICN Pharma-
ceutical). Quantitation was performed using a Molecular Dynamics
PhosphorImager and the ImageQuant Software.
Measurement of NRG Release from Cultured Neurons
Conditioned media from w30 cultures each of wt, NRG1 type III+/−,



































































bnd halved. One aliquot was treated with 100 g/ml soluble heparin
o bind heparin binding forms of NRG (types I and II). Media sam-
les were then assayed for NRG as previously described (Esper
nd Loeb, 2004). L6 myoblasts were plated at 50,000 cells per well
nd allowed to fuse and differentiate for 7 days. The cells were
xposed to the DRG media samples for 45 min, lysed, and the
rbB2 and erbB3 proteins were immunoprecipitated and analyzed
y Western blotting. Following a probe with anti-phosphotyrosine
4G10), the membrane was stripped and reprobed for total erbB
rotein. The intensity of each protein band was quantitatively mea-
ured with MetaMorph software.
eurite Membrane Preparation
eurite membranes were prepared from wt, NRG1 type III+/−, and
RG1 type III−/− DRG neurons grown in 35 mm dishes as previously
escribed (Maurel and Salzer, 2000). Membranes were centrifuged
nto serum starved, rat primary Schwann cells. Cells were then
ncubated at 37°C for an additional 20 min, lysed, and analyzed by
estern blotting.
entivirus Production and Infection
lentivirus expressing NRGβ1a type III HA was generated using
he ViraPower Lentiviral Expression System (Invitrogen) according
o the manufacturer’s instructions. The cDNA encoding NRGβ1a
ype III HA was cloned in a pLenti6/V5 plasmid using the Directional
OPOR Cloning Kit (Invitrogen) and confirmed by sequencing.
93FT cells were transfected together with pLP1, pLP2, and pLP/
SVG plasmids (Invitrogen) using Lipofectamine 2000 (Invitrogen).
upernatants were collected after 48 hr and stored at −80°C until
sed. Primary neurons, DRGs and SCGs, were infected the day
fter dissection with 100 l of the produced virus. Cells were kept
n the presence of the virus for 48 hr in MEM, 10% FBS, 2 mM
-glutamine, and antimitotic agents. Viral expression was con-
irmed by HA staining 11 days after infection. To quantitate the fiber
iameter in infected NRG1 type III−/− and control cultures, high-
ower images were acquired by confocal microscope and analyzed
sing Volocity software.
c Fusion Proteins and Binding Experiments
93FT cells were cotransfected with plasmids encoding erbB2-Fc
nd erbB3-Fc fusion proteins in media containing DMEM, 1%
ltra-Low IgG FBS (BioWhittaker), and 2 mM L-glutamine. After 72
r, the supernatant was collected, filtered, and erbB-Fc expression
as confirmed by Western blotting. Established explants of wt,
RG1 type III+/−, and NRG1 type III−/− DRG neurons were incubated
ith supernatant containing erbB2/erbB3 Fc for 2 hr at 37°C and
n anti-human Fc (Jackson ImmunoResearch) for 1 hr at 25°C.
eurons were then fixed, permeabilized, and stained for neurofil-
ment.
lectron Microscopy and Morphometry
ocultures were processed for EM as previously described (Melen-
ez-Vasquez et al., 2004). Analysis of sciatic nerves from wt and
RG1 type III+/− littermates was performed as described (Bhat et
l., 2001). Mice were anesthetized with pentobarbital and fixed via
ranscardial perfusion with 2% paraformaldehyde and 3.75% acro-
ein in 0.1 M phosphate buffer or with 2% paraformaldehyde and
% glutaraldehyde in cacodylate buffer (pH 7.3). One micron sec-
ions of whole sciatic nerves were stained with toluidine blue for
urvey by light microscopy. Ultrathin sections (70–100 nm thick) of
ciatic nerves were cut and counterstained with uranyl acetate and
eynold’s lead citrate or alcoholic uranyl acetate and permanga-
ate. Micrographs were taken with a Philips EM300, JEOL JEM
200EXII, or a Philips CM10 electron microscope (Eindhoven, The
etherlands) (Einheber et al., 1997; Rosenbluth et al., 2003).
Nonoverlapping digitized images of fiber cross-sections were
btained and analyzed from sciatic nerve using Image J software
National Institute of Health). G ratios were determined by dividing
he diameter of the axon by that of the total fiber diameter from
600 fibers in the sciatic nerve (four animals per genotype). The
otal number of unmyelinated fibers, the number of axons/Remak
undle, and the number of axons in Schwann cell pockets were
NRG1 Type III Determines Axon Ensheathment Fate
693determined from the same digitized images used for g ratio
analysis.
Electrophysiology
Compound action potentials were measured by drawing each end
of a nerve into a suction electrode; the n varied between 5 and 10
for all measurements. At the proximal end, the entire trunk was
held in the pipette, and stimuli were applied. At the distal end, tibial
and peroneal branches were placed sequentially in a pipette for
recording. Nerves were bathed in oxygenated Locke’s solution
containing 154 mM NaCl, 5.6 mM KCl, 2 mM CaCl2, 5 mM glucose,
and 10 mM HEPES (pH 7.4). Bath temperature was controlled with
a proportional heater. Sweeps were collected and analyzed in a
laboratory computer. The stimulus amplitude was first set for the
myelinated axons and was then raised until the signal from the
unmyelinated axons was maximal. To increase the signal-to-noise
ratio for C-fibers, 8–32 sweeps were averaged. Further details have
been published (Vabnick et al., 1999).
Statistical Analysis
Statistical analyses (Fischer’ s exact test, χ2, and t test) were per-
formed using the Prism Software package (GraphPad).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/47/5/681/DC1/.
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